Breaking News

Quintiles Relocates Central Lab in Japan

Quintiles has relocated its Global Central Lab in Japan from Saitama to Tokyo to allow for further expansion.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quintiles has relocated its Global Central Lab in Japan from Saitama to Tokyo to allow for further expansion. The new facility has expanded testing capabilities with an initial focus on safety testing. The lab started receiving and testing clinical trial samples and has received National Glycohemoglobin Standardization Program Level 1 certification for diabetes testing. Additionally, the new Japan lab is working towards certification by the College of American Pathologists (CAP). “The growth ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters